Chronic Inflammation Contributes to Tumor Growth: Possible Role of l-Selectin-Expressing Myeloid-Derived Suppressor Cells (MDSCs)
- 24 September 2018
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 42 (1) , 276-289
Abstract
Recent data have demonstrated that chronic inflammation is a crucial component of tumor initiation and progression. We previously reported that immature myeloid-derived suppressor cells (MDSCs) with immunosuppressive activity toward effector T cells were expanded in experimental chronic inflammation. We hypothesized that elevated levels of MDSCs, induced by chronic inflammation, may contribute to the progression of tumor growth. Using the Ehrlich carcinoma animal model, we found increased tumor growth in mice with chronic adjuvant arthritis, which was accompanied by a persistent increase in the proportion of splenic monocytic and granulocytic MDSCs expressing CD62L (l-selectin), when compared to tumor mice without adjuvant arthritis. Depletion of inflammation-induced MDSCs resulted in decreased tumor growth. In vitro studies demonstrated that increased expression of CD62L by MDSCs was mediated by TNFα, elevated concentrations of which were found in tumor mice subjected to chronic inflammation. Moreover, the addition of exogenous TNFα markedly enhanced the suppressive activity of bone marrow-derived MDSCs, as revealed by the ability to impair the proliferation of CD8+ T cells in vitro. This study provides evidence that chronic inflammation may promote tumor growth via induction of CD62L expression by MDSCs that can facilitate their migration to tumor and lymph nodes and modulation of their suppressor activity.Keywords
Funding Information
- Committee of Science of Ministry of Education and Science of the Republic of Kazakhstan (AP05131710)
This publication has 45 references indexed in Scilit:
- Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis InfectionPLOS ONE, 2013
- TNF signaling drives myeloid-derived suppressor cell accumulationJournal of Clinical Investigation, 2012
- Chronic Inflammation in Cancer DevelopmentFrontiers in Immunology, 2012
- Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10−/− miceBrain, Behavior, and Immunity, 2012
- Gr-1+ CD11b+ Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in ObesityJournal of Biological Chemistry, 2011
- C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cellsProceedings of the National Academy of Sciences, 2010
- Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1–dependent mechanism that is up-regulated by interleukin-13Blood, 2010
- TLR2-Mediated Expansion of MDSCs Is Dependent on the Source of Tumor ExosomesThe American Journal of Pathology, 2010
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsJournal of Clinical Investigation, 2010
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008